TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,836,050 | +1502.7% | 5,327,864 | +235.2% | 0.00% | – |
| Q2 2023 | $1,050,493 | -16.8% | 1,589,248 | +0.4% | 0.00% | – |
| Q1 2023 | $1,262,950 | -64.1% | 1,583,438 | +1.8% | 0.00% | – |
| Q4 2022 | $3,515,805 | +70.1% | 1,555,666 | +45.3% | 0.00% | – |
| Q3 2022 | $2,067,000 | -48.1% | 1,070,802 | 0.0% | 0.00% | – |
| Q2 2022 | $3,983,000 | -39.6% | 1,070,802 | +5.8% | 0.00% | – |
| Q1 2022 | $6,599,000 | -35.9% | 1,012,164 | +14.5% | 0.00% | – |
| Q4 2021 | $10,295,000 | -31.4% | 883,647 | +9.7% | 0.00% | – |
| Q3 2021 | $15,002,000 | +12.6% | 805,718 | +28.2% | 0.00% | – |
| Q2 2021 | $13,327,000 | +42.6% | 628,644 | +36.6% | 0.00% | – |
| Q1 2021 | $9,343,000 | -24.3% | 460,248 | -1.0% | 0.00% | – |
| Q4 2020 | $12,337,000 | +634.3% | 464,850 | +519.8% | 0.00% | – |
| Q3 2020 | $1,680,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |